Agios Pharmaceuticals (AGIO) FCF Margin Growth (1y) (2013 - 2026)
Agios Pharmaceuticals (AGIO) FCF Margin Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,187.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Agios Pharmaceuticals | 2.13 Bn | 2.13 Bn | 19.43 Mn | 70,952.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 70,952.00 |
| Dec 31, 2025 | 77,461.00 |
| Sep 30, 2025 | 26,546.00 |
| Jun 30, 2025 | 21,683.00 |
| Mar 31, 2025 | -6,692.00 |
| Dec 31, 2024 | -22,181.00 |
| Sep 30, 2024 | -10,649.00 |
| Jun 30, 2024 | 14,553.00 |
| Mar 31, 2024 | 48,456.00 |
| Dec 31, 2023 | 39,375.00 |
| Sep 30, 2023 | 133,138.00 |
| Jun 30, 2023 | 29,115.00 |
| Mar 31, 2023 | 1.04 Mn |
| Dec 31, 2020 | 28,747.00 |
| Sep 30, 2020 | 509.00 |
| Jun 30, 2020 | 26,336.00 |
| Mar 31, 2020 | 22,118.00 |
| Dec 31, 2019 | -1,444.00 |
| Sep 30, 2019 | 7,765.00 |
| Jun 30, 2019 | -17,444.00 |